✦ LIBER ✦

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma

✍ Scribed by Stebbing, Justin; Powles, Thomas; McPherson, Kirsty; Shamash, Jonathan; Wells, Paula; Sheaff, Michael T.; Slater, Sarah; Rudd, Robin M.; Fennell, Dean; Steele, Jeremy P.C.

Book ID: 119319929
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 161 KB
Volume: 63
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2008.04.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A biomarker profile for predicting effic

A biomarker profile for predicting efficacy of cisplatin–vinorelbine therapy in malignant pleural mesothelioma

✍ Zarah Glad Zimling, Jens Benn Sørensen… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 813 KB

Phase II trial of vinorelbine and oxalip

Phase II trial of vinorelbine and oxaliplatin in patients with malignant pleural mesothelioma

✍ Steele, J.P.C; Shamash, J; Evans, M.T; Gower, N.H; Rudd, R.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Phase II trial of vinorelbine and oxalip

Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma

✍ Fennell, Dean A.; C. Steele, Jeremy P.; Shamash, Jonathan; Sheaff, Michael T.; E 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Weekly systemic combination of cisplatin

Weekly systemic combination of cisplatin and interferon α2a in diffuse malignant pleural mesothelioma

✍ Purohit, A.; Moreau, L.; Dietemann, A.; Seibert, R.; Pauli, G.; Wihlm, J.M.; Quo 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Efficacy and safety of iodopovidone pleu

Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions

✍ Jose D.A. NETO; Sandro F.Q. De OLIVEIRA; Sylvana P. VIANNA; Ricardo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Efficacy and Safety of Tunneled Pleural

Efficacy and Safety of Tunneled Pleural Catheters in Adults with Malignant Pleural Effusions: A Systematic Review

✍ Margaret E. M. Van Meter; Kanako Y. McKee; R. Jeffrey Kohlwes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 758 KB

## Background Malignant pleural effusions (MPE) are a frequent cause of dyspnea and discomfort at the end of cancer patients' lives. The tunneled indwelling pleural catheter (TIPC) was approved by the FDA in 1997 and has been investigated as a treatment for MPE. ## Objective To systematically rev